- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Regional Health Properties: Unverlangte Übernahmeangebote und Aktionärsklage vor Fusion mit SunLink | 1 | Investing.com Deutsch | ||
| Fr | SunLink Health Systems kündigt Sonderdividende vor Fusionsabstimmung an | 1 | Investing.com Deutsch | ||
| Fr | SUNLINK HEALTH SYSTEMS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | SunLink Health Systems gets NYSE notice for non-compliance | 1 | Seeking Alpha | ||
| SUNLINK HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 08.07. | SunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing Standards | 75 | Business Wire | It Failed to Hold Its Annual Meeting of Stockholders for the Fiscal Year Ending on June 30, 2025, as Set Forth in Section 704 of the NYSE American Company Guide
ATLANTA--(BUSINESS WIRE)--SunLink... ► Artikel lesen | |
| 23.06. | Regional Health Properties und SunLink Health Systems verlängern Frist für Fusionsvereinbarung | 1 | Investing.com Deutsch | ||
| 23.06. | SUNLINK HEALTH SYSTEMS INC - 8-K, Current Report | 3 | SEC Filings | ||
| 13.05. | SunLink Health Systems GAAP EPS of -$0.09, revenue of $7.32M | 1 | Seeking Alpha | ||
| 13.05. | SUNLINK HEALTH SYSTEMS INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 15.04. | SUNLINK HEALTH SYSTEMS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 15.04. | Regional Health Properties, Inc.: Regional Health Properties And Sunlink Health Systems Revise All-stock Merger Transaction | 160 | GlobeNewswire (Europe) | Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. ("SunLink") (NYSE American: SSY) jointly... ► Artikel lesen | |
| 12.02. | SunLink Health Systems GAAP EPS of -$0.19, revenue of $7.93M | 1 | Seeking Alpha | ||
| 12.02. | SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results | 108 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,070,000 (or a loss of $0.15 per fully diluted share) for its... ► Artikel lesen | |
| 12.02. | SUNLINK HEALTH SYSTEMS INC - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.01. | Regional Health Properties, Inc.: Regional Health Properties And Sunlink Health Systems To Merge In An All-stock Transaction | 190 | GlobeNewswire (Europe) | Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA, Jan. 06,... ► Artikel lesen | |
| 12.11.24 | SunLink Health Systems, Inc. Announces Fiscal 2025 First Quarter Results | 122 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first... ► Artikel lesen | |
| 01.10.24 | SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results | 148 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $652,000 (or a loss of $0.09 per fully diluted share) for its fourth... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,108 | +4,85 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,740 | +2,21 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,046 | -1,46 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,216 | +4,85 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,921 | +4,42 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| VERU | 0,510 | -1,07 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
| VOLITIONRX | 0,680 | -1,31 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
| EKSO BIONICS | 3,790 | +1,61 % | Ekso Bionics Holdings, Inc.: Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country | ||
| IMUNON | 0,484 | +2,98 % | Imunon, Inc.: IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan | Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage... ► Artikel lesen | |
| BEYOND AIR | 2,500 | 0,00 % | XFRA 48L0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBEYOND AIR INC.... ► Artikel lesen | |
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,466 | -0,11 % | Novacyt S.A. - Launch of LightBench® Discover | ||
| AROVELLA THERAPEUTICS | 0,050 | -8,26 % | AROVELLA THERAPEUTICS LIMITED: Notification regarding unquoted securities - ALA | ||
| FRESENIUS | 40,890 | -0,87 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen |
SUNLINK HEALTH SYSTEMS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,86 % bei einem Aktienkurs von 1,150 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SUNLINK HEALTH SYSTEMS INC finden Sie auf Wallstreet Online.